Diabetes decisions — 2025

The Board remands the appeal to obtain an opinion on whether the Veteran's service-connected thoracolumbar spine disorder caused or contributed to his obesity, hypertension, and diabetes mellitus, which in turn may have contributed to his death.

The Board granted service connection for bilateral hallux rigidus and assigned a 60 percent rating from September 9, 2019, for residuals of prostate cancer with voiding dysfunction. It also granted ratings in excess of 20 percent for type II diabetes mellitus and right and left lower extremity peripheral neuropathy of the anterior crural nerve.

The Board denied the veteran's claim for a rating in excess of 20 percent for diabetes mellitus type II, as there was no evidence that his condition required one or more daily injections of insulin, restricted diet, and regulation of activities.

The Board denied service connection for diabetes, finding no medical evidence supporting a link between the Veteran's diabetes and his service-connected lumbar spine strain with IVDS.

The Board remands the claims for service connection for Type II diabetes mellitus, a dental disability, and bilateral hearing loss due to pre-decisional errors in not requesting relevant records.

The Board granted service connection for coronary artery disease and diabetes mellitus, type 2 due to the Veteran's exposure to herbicide agents during his service in Korea. The claim for a brain tumor was remanded for further development.

The Board granted service connection for diabetes mellitus and hypertension based on new and relevant evidence, but remanded the claims for further development regarding the onset of these conditions during active duty or ACDUTRA.

The Board denied the claims for earlier effective dates, service connection for various conditions, and remanded some issues for further development.

The Board remands the claims for increased ratings due to duty to assist errors that occurred prior to the October 2023, December 2023, and January 2024 rating decisions on appeal.

The Board denied an earlier effective date for the Veteran's service-connected diabetes mellitus type 1, as no claim or intent to file a claim was received prior to April 21, 2023.

The Board denied the veteran's claims for increased ratings and service connection, finding that the evidence did not support higher ratings or service connection for any of the claimed conditions.

The Board denied a compensable rating for pseudofolliculitis barbae, dismissed the service connection claim for sleep disturbances as moot, and denied service connection claims for nonspecific neurological complaints, hemorrhoids, diabetes mellitus type II, and tinnitus.

The Board granted service connection for diabetes mellitus, finding the evidence to be approximately balanced as to exposure to herbicide agents and causation.

The Board remands all issues on appeal for additional development, including verification of potential exposure to herbicide agents and other chemicals, as well as obtaining any relevant treatment records.

The Veteran was granted a 70 percent disability rating for his service-connected PTSD and major depressive disorder from January 24, 2013 to September 6, 2016, but an increased rating of more than 100 percent is not available as a matter of law.

The Board granted service connection for obstructive sleep apnea (OSA) as secondary to the Veteran's service-connected depressive disorder with alcohol use disorder, but denied increased ratings and service connection for other conditions.

The Veteran's service-connected diabetes and upper and lower peripheral neuropathy rendered him unable to work in any job, sedentary or non-sedentary, making a total disability rating based on individual unemployability (TDIU) appropriate.

The Board remands the claims for service connection due to a pre-decisional duty to assist error regarding herbicide agent exposure.

The Board denied the Veteran's claims for an earlier effective date prior to August 10, 2022, for service connection for coronary artery disease and diabetes mellitus type II, as these conditions are subject to the PACT Act's effective date.

The Board denied an earlier effective date for the grant of service connection for diabetes mellitus, type II and a higher disability rating. The claims for service connection for peripheral neuropathy were remanded.